May 10, 2023 7:00am EDT Immunocore Reports First Quarter 2023 Financial Results and Provides Business Update
May 03, 2023 4:30pm EDT Immunocore to present at the Bank of America Securities 2023 Health Care Conference
Apr 18, 2023 7:00am EDT Immunocore presents new KIMMTRAK data confirming association between early ctDNA reduction and longer overall survival
Apr 11, 2023 7:00am EDT Immunocore to present at the 22nd Annual Needham Virtual Healthcare Conference
Feb 23, 2023 7:00am EST Immunocore to Report Fourth Quarter and Full Year 2022 Earnings and Host Call on March 1, 2023
Feb 22, 2023 7:00am EST Immunocore announces initial Phase 1 safety and pharmacodynamic activity data with first soluble TCR therapy for people living with HIV